Chronic kidney disease, atrial fibrillation, and stroke: risk scores in the era of SGLT2i, non-steroidal MRA, and GLP-1 RA, and presence of high competing mortality

Study limitation reported by the research below: “Sample size tag omitted as no study population is enrolled.”